THE USE OF ERGOTAMINE COMPOUNDS IN THE TREATMENT OF ACUTE SIMPLE ANXIETY STATES
Abstract
A report is made on 59 cases of acute anxiety treated with ergotamine tartrate, 37 cases treated with ergonovine maleate, and 36 cases treated as controls with calcium lactate. Results are given therapeutically and it is indicated that, while these drugs do act as antisympathetic compounds and to some degree ameliorate symptoms of jitteriness and tension, their potential hazard and the routine required for their administration is sufficiently complex to limit their use to special instances.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
